Skip to content

Clinical trials

Phase 2 Anemia, Sickle Cell trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia, Sickle Cell Phase: Phase 2 Clear all

198 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20014
20022
20032
20049
20054
20065
20075
20084
20097
20107
20117
20126
201310
201411
20156
201610
201714
201812
20199
20206
20217
20228
202310
20246
20257
20269

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed104
Terminated31
Recruiting27
Unknown status13
Withdrawn13
Active, not recruiting9
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
St. Jude Children's Research Hospital10
National Heart, Lung, and Blood Institute (NHLBI)9
Novartis Pharmaceuticals8
UCSF Benioff Children's Hospital Oakland6
Children's Hospital Medical Center, Cincinnati5
Emory University5
Johns Hopkins University5
New York Medical College5
University of North Carolina, Chapel Hill4
Assistance Publique - Hôpitaux de Paris3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia, Sickle Cell198
Vaso-Occlusive Crises21
Thalassemia19
beta-Thalassemia14
Anemia13
Hemoglobinopathies12
Acute Chest Syndrome9
Hematologic Diseases9
Genetic Diseases, Inborn7
Anemia, Diamond-Blackfan6

Trials

Showing 26 to 50 of 198. Each trial links to its page on Pharma Observatory.

98 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.